These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 12589396)

  • 1. Changes in human in vivo serotonin and dopamine transporter availabilities during chronic antidepressant administration.
    Kugaya A; Seneca NM; Snyder PJ; Williams SA; Malison RT; Baldwin RM; Seibyl JP; Innis RB
    Neuropsychopharmacology; 2003 Feb; 28(2):413-20. PubMed ID: 12589396
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Validation of [(123)I]beta-CIT SPECT to assess serotonin transporters in vivo in humans: a double-blind, placebo-controlled, crossover study with the selective serotonin reuptake inhibitor citalopram.
    de Win MM; Habraken JB; Reneman L; van den Brink W; den Heeten GJ; Booij J
    Neuropsychopharmacology; 2005 May; 30(5):996-1005. PubMed ID: 15770240
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular mechanism of citalopram and cocaine interactions with neurotransmitter transporters.
    Ravna AW; Sylte I; Dahl SG
    J Pharmacol Exp Ther; 2003 Oct; 307(1):34-41. PubMed ID: 12944499
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantification of striatal dopamine transporters with 123I-FP-CIT SPECT is influenced by the selective serotonin reuptake inhibitor paroxetine: a double-blind, placebo-controlled, crossover study in healthy control subjects.
    Booij J; de Jong J; de Bruin K; Knol R; de Win MM; van Eck-Smit BL
    J Nucl Med; 2007 Mar; 48(3):359-66. PubMed ID: 17332612
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Displacement of serotonin and dopamine transporters by venlafaxine extended release capsule at steady state: a [123I]2beta-carbomethoxy-3beta-(4-iodophenyl)-tropane single photon emission computed tomography imaging study.
    Shang Y; Gibbs MA; Marek GJ; Stiger T; Burstein AH; Marek K; Seibyl JP; Rogers JF
    J Clin Psychopharmacol; 2007 Feb; 27(1):71-5. PubMed ID: 17224717
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of chronic antidepressant treatments on serotonin transporter function, density, and mRNA level.
    Benmansour S; Cecchi M; Morilak DA; Gerhardt GA; Javors MA; Gould GG; Frazer A
    J Neurosci; 1999 Dec; 19(23):10494-501. PubMed ID: 10575045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-amines, drugs without an amine nitrogen, potently block serotonin transport: novel antidepressant candidates?
    Goulet M; Miller GM; Bendor J; Liu S; Meltzer PC; Madras BK
    Synapse; 2001 Dec; 42(3):129-40. PubMed ID: 11746710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SPECT imaging of dopamine and serotonin transporters with [123I]beta-CIT: pharmacological characterization of brain uptake in nonhuman primates.
    Laruelle M; Baldwin RM; Malison RT; Zea-Ponce Y; Zoghbi SS; al-Tikriti MS; Sybirska EH; Zimmermann RC; Wisniewski G; Neumeyer JL
    Synapse; 1993 Apr; 13(4):295-309. PubMed ID: 7683143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dopamine and serotonin transporters in patients with schizophrenia: an imaging study with [(123)I]beta-CIT.
    Laruelle M; Abi-Dargham A; van Dyck C; Gil R; D'Souza DC; Krystal J; Seibyl J; Baldwin R; Innis R
    Biol Psychiatry; 2000 Mar; 47(5):371-9. PubMed ID: 10704949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serotonin clearance in vivo is altered to a greater extent by antidepressant-induced downregulation of the serotonin transporter than by acute blockade of this transporter.
    Benmansour S; Owens WA; Cecchi M; Morilak DA; Frazer A
    J Neurosci; 2002 Aug; 22(15):6766-72. PubMed ID: 12151556
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brain serotonin transporter availability predicts treatment response to selective serotonin reuptake inhibitors.
    Kugaya A; Sanacora G; Staley JK; Malison RT; Bozkurt A; Khan S; Anand A; Van Dyck CH; Baldwin RM; Seibyl JP; Charney D; Innis RB
    Biol Psychiatry; 2004 Oct; 56(7):497-502. PubMed ID: 15450785
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Further studies on conformationally constrained tricyclic tropane analogues and their uptake inhibition at monoamine transporter sites: synthesis of (Z)-9-(substituted arylmethylene)-7-azatricyclo[4.3.1.0(3,7)]decanes as a novel class of serotonin transporter inhibitors.
    Zhang A; Zhou G; Hoepping A; Mukhopadhyaya J; Johnson KM; Zhang M; Kozikowski AP
    J Med Chem; 2002 Apr; 45(9):1930-41. PubMed ID: 11960503
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serotonin transporters in dopamine transporter imaging: a head-to-head comparison of dopamine transporter SPECT radioligands 123I-FP-CIT and 123I-PE2I.
    Ziebell M; Holm-Hansen S; Thomsen G; Wagner A; Jensen P; Pinborg LH; Knudsen GM
    J Nucl Med; 2010 Dec; 51(12):1885-91. PubMed ID: 21078806
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [11C]-DASB, a tool for in vivo measurement of SSRI-induced occupancy of the serotonin transporter: PET characterization and evaluation in cats.
    Ginovart N; Wilson AA; Meyer JH; Hussey D; Houle S
    Synapse; 2003 Feb; 47(2):123-33. PubMed ID: 12454950
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Species-scanning mutagenesis of the serotonin transporter reveals residues essential in selective, high-affinity recognition of antidepressants.
    Mortensen OV; Kristensen AS; Wiborg O
    J Neurochem; 2001 Oct; 79(2):237-47. PubMed ID: 11677251
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effects of antidepressant treatment on serotonergic and dopaminergic systems in Fawn-Hooded rats: a quantitative autoradiography study.
    Chen F; Lawrence AJ
    Brain Res; 2003 Jun; 976(1):22-9. PubMed ID: 12763618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Escitalopram, the S-(+)-enantiomer of citalopram, is a selective serotonin reuptake inhibitor with potent effects in animal models predictive of antidepressant and anxiolytic activities.
    Sánchez C; Bergqvist PB; Brennum LT; Gupta S; Hogg S; Larsen A; Wiborg O
    Psychopharmacology (Berl); 2003 Jun; 167(4):353-62. PubMed ID: 12719960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Change of dopamine transporter activity (DAT) during the action of bupropion (in depression)].
    Szabó Z; Argyelán M; Kanyó B; Pávics L; Janka Z
    Neuropsychopharmacol Hung; 2004 Jun; 6(2):79-81. PubMed ID: 15787205
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sex differences in [123I]beta-CIT SPECT measures of dopamine and serotonin transporter availability in healthy smokers and nonsmokers.
    Staley JK; Krishnan-Sarin S; Zoghbi S; Tamagnan G; Fujita M; Seibyl JP; Maciejewski PK; O'Malley S; Innis RB
    Synapse; 2001 Sep; 41(4):275-84. PubMed ID: 11494398
    [TBL] [Abstract][Full Text] [Related]  

  • 20. S-[18F]fluoromethyl-(+)-McN5652, a PET tracer for the serotonin transporter: evaluation in rats.
    Marjamäki P; Zessin J; Eskola O; Grönroos T; Haaparanta M; Bergman J; Lehikoinen P; Forsback S; Brust P; Steinbach J; Solin O
    Synapse; 2003 Jan; 47(1):45-53. PubMed ID: 12422372
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.